Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy-Reference-Cited by-同舟云学术

Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy

Published:2019-01-08 Issue:3 Volume:24 Page:359-366
ISSN:1382-4147
Container-title:Heart Failure Reviews
language:en
Short-container-title:Heart Fail Rev

Author:

Rigopoulos Angelos G.^ORCID,Ali Muhammad,Abate Elena,Matiakis Marios,Melnyk Hannes,Mavrogeni Sophie,Leftheriotis Dionyssios,Bigalke Boris,Noutsias Michel

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10741-018-09767-w.pdf

Reference50 articles.

1. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779

2. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232–2239

3. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348:295–303

4. Wigle ED (1987) Hypertrophic cardiomyopathy: a 1987 viewpoint. Circulation 75:311–322

5. Sherrid MV (2006) Pathophysiology and treatment of hypertrophic cardiomyopathy. Prog Cardiovasc Dis 49:123–151

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of present and future pharmaco‐structural therapies for hypertrophic cardiomyopathy;Clinical Cardiology;2024-01

2. Case Report: Integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm;Frontiers in Cardiovascular Medicine;2023-11-01

3. A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy;Current Cardiology Reviews;2023-07

4. Association between left ventricular reverse remodeling and long-term outcomes after alcohol septal ablation for hypertrophic obstructive cardiomyopathy;The International Journal of Cardiovascular Imaging;2022-11-02

5. Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review;Journal of Clinical Medicine;2022-06-14